Combined BRAF and PIM1 inhibitory therapy for papillary thyroid carcinoma based on BRAFV600E regulation of PIM1: Synergistic effect and metabolic mechanisms
Article in Neoplasia (April 2024)
The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.
Article in Neoplasia (April 2024)
Article in Communications Medicine (February 2024)
Article in Cancer Immunology, Immunotherapy (January 2024)